- Home
- APYX vs VRCA Comparison
APYX vs VRCA Comparison
Compare APYX & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APYX
- VRCA
- Stock Information
- Founded
- APYX 1982
- VRCA 2013
- Country
- APYX United States
- VRCA United States
- Employees
- APYX N/A
- VRCA N/A
- Industry
- APYX Medical/Dental Instruments
- VRCA Biotechnology: Pharmaceutical Preparations
- Sector
- APYX Health Care
- VRCA Health Care
- Exchange
- APYX Nasdaq
- VRCA Nasdaq
- Market Cap
- APYX 36.8M
- VRCA 43.0M
- IPO Year
- APYX 1987
- VRCA 2018
- Fundamental
- Price
- APYX $1.16
- VRCA $0.44
- Analyst Decision
- APYX Hold
- VRCA Hold
- Analyst Count
- APYX 2
- VRCA 5
- Target Price
- APYX N/A
- VRCA $6.00
- AVG Volume (30 Days)
- APYX 54.9K
- VRCA 237.2K
- Earning Date
- APYX 05-08-2025
- VRCA 05-13-2025
- Dividend Yield
- APYX N/A
- VRCA N/A
- EPS Growth
- APYX N/A
- VRCA N/A
- EPS
- APYX N/A
- VRCA N/A
- Revenue
- APYX $47,288,000.00
- VRCA $7,566,000.00
- Revenue This Year
- APYX $1.85
- VRCA $127.58
- Revenue Next Year
- APYX $7.72
- VRCA $88.06
- P/E Ratio
- APYX N/A
- VRCA N/A
- Revenue Growth
- APYX N/A
- VRCA 47.66
- 52 Week Low
- APYX $0.76
- VRCA $0.38
- 52 Week High
- APYX $1.99
- VRCA $11.41
- Technical
- Relative Strength Index (RSI)
- APYX 54.22
- VRCA 44.12
- Support Level
- APYX $1.04
- VRCA $0.39
- Resistance Level
- APYX $1.31
- VRCA $0.48
- Average True Range (ATR)
- APYX 0.13
- VRCA 0.05
- MACD
- APYX 0.03
- VRCA -0.00
- Stochastic Oscillator
- APYX 69.07
- VRCA 44.95
About APYX Apyx Medical Corporation
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.